Skip to main content
ZHEJIANG ZHENYUAN SHARE CO.,LTD. logo

ZHEJIANG ZHENYUAN SHARE CO.,LTD. — Investor Relations & Filings

Ticker · 000705 ISIN · CNE0000007L4 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,561 across all filing types
Latest filing 2026-05-20 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 000705

About ZHEJIANG ZHENYUAN SHARE CO.,LTD.

https://www.zjzy.com

Zhejiang Zhenyuan Share Co., Ltd. focuses on the wholesale and retail distribution of pharmaceutical products, traditional Chinese medicine (TCM), and medical devices. The company operates a comprehensive network of retail pharmacies and logistics centers, providing a wide range of chemical drugs, TCM decoction pieces, and health-related commodities. Its business model integrates the procurement, storage, and sale of medical supplies, catering to healthcare institutions and individual consumers. The company is noted for its heritage in traditional medicine and its commitment to modern pharmaceutical supply chain management, ensuring the quality and accessibility of healthcare products through standardized distribution channels and professional pharmacy services.

Recent filings

Filing Released Lang Actions
浙江震元2025年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 94% confidence The document is an official announcement of the resolutions and voting results from the 2025 shareholders’ meeting, detailing vote counts and percentages on each proposal. This matches the definition for “Declaration of Voting Results & Voting Rights Announcements.”
2026-05-20 Chinese
锦天城律师事务所关于浙江震元2025年年度股东大会法律意见书
Regulatory Filings Classification · 82% confidence The document is a “法律意见书” (legal opinion letter) issued by Shanghai Allbright Law Offices on the legality of convening and holding Zhejiang Zhenyuan’s 2025 shareholders’ meeting, covering procedures, attendee qualifications and detailed vote tallies. It is not the company’s AGM presentation (AGM-R), not a proxy solicitation (PSI), nor a standalone vote-results announcement by the issuer (DVA). It is a third-party compliance/legal opinion, which falls under general regulatory/compliance filings. Therefore, it should be classified as a Regulatory Filing (RNS).
2026-05-20 Chinese
关于参加浙江辖区上市公司2026年投资者网上集体接待日暨2025年度业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about the company's participation in an investor online collective reception day and a 2025 annual performance explanation meeting. It mentions the event date, participation details, and invites investors to submit questions. The document does not contain actual financial statements or detailed financial analysis but rather serves as a notice for an upcoming investor event focused on discussing the annual performance. The document length is short (738 characters), and it is clearly an announcement rather than the report itself. Therefore, it fits best as an Investor Presentation (IP) since it relates to a presentation event for investors discussing financial results and company strategy.
2026-05-07 Chinese
关于公司补缴税款的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the company's tax payment adjustment, specifically about a subsidiary's tax payment and its impact on future financial statements. It does not contain detailed financial data or a full report but is a regulatory announcement about a tax-related matter. The length is only 553 characters, indicating it is a brief notice rather than a full report. It fits best under Regulatory Filings (RNS) as it is a compliance-related announcement without substantive financial statements or detailed report content.
2026-04-08 Chinese
关于为子公司震元生物提供担保的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Zhejiang Zhenyuan Co., Ltd. regarding the progress of providing guarantees for its subsidiary Zhejiang Zhenyuan Biotechnology Co., Ltd. It details the guarantee contract, the approval process by the board, the financial status of the subsidiary, and the scope and terms of the guarantee. The document is a formal disclosure about a financing-related guarantee arrangement rather than a financial report or audit. It does not contain comprehensive financial statements or earnings data but focuses on the guarantee and related board approval. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company financing activities and guarantees.
2026-04-01 Chinese
浙江震元第十一届董事会2025年第六次临时会议决议公告
Board/Management Information Classification · 95% confidence The document is titled as a resolution announcement from the company's board of directors regarding the 6th interim meeting of the 11th board in 2025. It details the meeting attendance, election of a director to execute company affairs, confirmation of audit committee members, and voting results. There is no financial data, no mention of annual or quarterly reports, no earnings data, no legal proceedings, no capital changes, and no shareholder voting results beyond board resolutions. The document is an announcement of board/management decisions and changes in board roles. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is a formal announcement of board meeting resolutions, not a full report or financial statement.
2025-12-16 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.